WO2002077638A2 - Silicon microprobe with integrated biosensor for measuring glucose content in blood - Google Patents
Silicon microprobe with integrated biosensor for measuring glucose content in blood Download PDFInfo
- Publication number
- WO2002077638A2 WO2002077638A2 PCT/US2002/009163 US0209163W WO02077638A2 WO 2002077638 A2 WO2002077638 A2 WO 2002077638A2 US 0209163 W US0209163 W US 0209163W WO 02077638 A2 WO02077638 A2 WO 02077638A2
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- microprobe
- biosensor
- silicon substrate
- analyte
- signal
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/68—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
- A61B5/6846—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be brought in contact with an internal body part, i.e. invasive
- A61B5/6847—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be brought in contact with an internal body part, i.e. invasive mounted on an invasive device
- A61B5/685—Microneedles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
- A61B5/14532—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue for measuring glucose, e.g. by tissue impedance measurement
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
- A61B5/14546—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue for measuring analytes not otherwise provided for, e.g. ions, cytochromes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/68—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
- A61B5/6846—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be brought in contact with an internal body part, i.e. invasive
- A61B5/6847—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be brought in contact with an internal body part, i.e. invasive mounted on an invasive device
- A61B5/6848—Needles
- A61B5/6849—Needles in combination with a needle set
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B2560/00—Constructional details of operational features of apparatus; Accessories for medical measuring apparatus
- A61B2560/04—Constructional details of apparatus
- A61B2560/0406—Constructional details of apparatus specially shaped apparatus housings
- A61B2560/0412—Low-profile patch shaped housings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/0002—Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network
Definitions
- This invention relates to silicon microprobes, and more particularly to micro ro es with biosensor capability incorporated therein for measuring analyte concentrations in a subject's blood, tissue, or other bodily fluids.
- Diabetes mellitus is an insidious disease which affects more than 15 million Americans. About 1.5 million of these are Type I diabetics (insulin- dependent) and 12 to 14 million are Type II diabetics (noninsulin-dependent) .
- the characteristics of diabetes include chronic and persistently high levels of glucose in blood and in urine . Although urine glucose has been used to monitor glucose levels, the measurement of blood glucose is more reliable and logistically feasible. Blood glucose has therefore become the most commonly followed clinical marker for monitoring the progress of diabetes (and other diseases) to determine treatment and control protocols. Glucose levels are routinely measured in doctors' offices, clinical laboratories, and hospitals.
- the smallest lancet or needle currently marketed for blood sampling has a diameter between 300 micrometers and 500 micrometers, and is constructed of stainless steel with beveled edges. Due to the large cross section of these lancets, fingertip lancing is painful and frequent lancing causes calluses, impairment of the use of hands, psychological trauma and other unpleasant consequences. Further, blood samples recovered from the patient must be transferred to a test strip or cartridge for assaying analyte concentrations. Obtaining blood samples by lancing and performing the analysis can be messy as well as painful for the patient .
- the analyte concentration is determined by a biosensor built into the microprobe, which is in data communication with an external meter via an analyte signal.
- a blood sample is not transferred from the subject to an external test mechanism as in the prior art.
- the present self-contained process minimizes messy blood smears, which is convenient for the subjects. Further, the closed nature of the present process also minimizes ambient exposure of the subject's blood. Blood may harbor undesirable biological forms (such as HIV) which could contaminate the local environment constituting a biohazard. By eliminating the blood transfer step, the present microprobe avoids such hazard.
- the subject simply places the microprobe in a holder against the skin and waits for a signal to be sent to an external meter.
- the microprobe penetrates the stratum corneum (the tough outer layer of the skin) and contacts the tissue within.
- a separate ex vivo testing step with testing strips and the like is not required.
- the present one-step process eliminates the following prior art steps :
- a biosensor may be integrated into the surface of the microprobe. Alternately, the biosensor may be placed in a cavity in the surface of the silicon.
- Silicon is compatible with integrated circuit (IC) fabrication and MEMS (microelectromechanical systems) technologies employing well established masking, deposition, etching, and high resolution photolithographic techniques.
- IC integrated circuit
- MEMS microelectromechanical systems
- the present microprobe devices may be fabricated in mass quantities from silicon wafers through automatic IC and MEMS processing steps at minimal cost per device .
- the dimensions of the probe are very small and cause minimal tissue displacement and related lateral tissue pressure and nerve ending contact. In some cases the displacement may be so minimal that the subject feels no sensation at all during the process. For example in a clinical trial of 62 patients using a microprobe with a thickness of 100 micrometers, the majority found the insertion and retraction of the microprobe device in the arm to be painless. Of the total patients tested, 15% could not even feel the probe penetration and an additional 58% found the penetration to be barely noticeable.
- the microprobe device retains the single-crystal structure of the silicon starting wafer and can reliably penetrate skin without breakage because of the strength provided by this single-crystal structure.
- the strength of the miniature probe may be further increased by optimal shaping. Data from skin puncturing tests show that the average force required to puncture the skin (0.038 Newton) is minimal compared to the buckling force required to break the probe (0.134 Newton).
- the biosensor may be located near the probe tip for maximum penetration.
- the biosensors may be placed in a cavity in the surface of the silicon.
- the probe accesses the blood, and the analyte signal is carried along the length of the probe to the ex vivo environment by conductive leads .
- the biosensor may be distant from the probe on an ex vivo portion of the device, and not in direct contact with the analyte tissue.
- the blood is transported from the in vivo probe tip to the ex vivo portion by one or more channels.
- biosensor may be formed by IC fabrication and are significantly smaller than the microprobe.
- biosensors may be spaced along a single microprobe for sensing several analytes per penetration, or for sensing the same analyte at different depths.
- a biosensor microprobe device for providing a signal to an external analyte meter.
- the signal indicates analyte presence in an analyte-containing fluid of a subject.
- the device is fabricated from a silicon wafer and has a body portion and a microprobe portion.
- the microprobe has a body end connected to the body portion, and having a penetration end extending away from the body portion for penetrating into the subject to access the bodily fluid.
- a biosensor integrated into the silicon substrate senses analyte presence and provides a signal in response to the analyte presence.
- FIG. 1A is a plan view of in vivo microprobe device 10 showing biosensor 12 on probe 16 ;
- FIG. IB is a side view of device 10 of FIG. 1A;
- FIG. 2A is a plan view of ex vivo device 20 showing biosensor 22 on body 24;
- FIG. 2B is a sectional side view of device 20 of FIG. 2A along line 2B- 2B showing biosensor 22 mounted in cavity 20C on silicon substrate 20S;
- FIG. 2C is a sectional view across probe 20 of FIG. 2A along line 2C-2C showing V-groove 26G in silicon substrate 2OS;
- FIG. 3A is a plan view of device 30 showing multiple biosensors 32D and 32M and 32S on probe 36;
- FIG. 3B is a side view of device 30 of FIG. 3A;
- FIG. 4A is a plan view of device 40 showing optical biosensor 42 and waveguide 42W on probe 46;
- FIG. 4B is a sectional side view of device 40 of FIG. 4A along line 4B- 4B showing the optical biosensor mounted in hole 40H through silicon substrate 40S;
- FIG. 5A is a plan view of microprobe assembly 50A showing cover member 58C and base member 58B;
- FIG. 5B is a sectional side view of assembly 50A of FIG. 5A along line 5B-5B showing transmitter 54T and battery 54B;
- FIG. 6 is a chart comparing the average pain perception values for the silicon microprobe device with those for a conventional metal lancet.
- each reference numeral in the above figures indicates the figure in which an element or feature is most* prominently shown.
- the second digit indicates related elements or features, and a final letter (when used) indicates a sub-portion of an element or feature.
- Microprobe Device 10 10A Front Side 10A 10F Silicon Oxide Film 10F 10B Back Side 10B 10S Silicon Substrate 10S
- Microprobe Device 20 20A Front Side 20A 20C Cavity 20C 20S Silicon Substrate 20S
- Microprobe device 10 provides an analyte signal from biosensor 12 to an external analyte meter (not shown) indicating analyte presence in an analyte- containing fluid of a subject (not shown) .
- Silicon substrate 10S extends in the X length dimension, and the Y width dimension, and the Z thickness dimension, forming large body portion 14 and pointed microprobe portion 16 (as shown in FIG. 1A) .
- the substrate has front side 10A into which the biosensor is integrated and back side 10B (as shown in FIG. IB) .
- the microprobe has a body end 16B connected to body 14, and a penetration end 16P extending away from the body in the X length dimension for penetrating into the subject to access the bodily fluid.
- a suitable signal interface structure such as electrical contact pads 14P may be deposited onto a side of silicon substrate 10S on body 14, for sliding contact connection with the analyte meter.
- a suitable signal carrier such as conductive leads 12L may be deposited onto a side of the silicon substrate between biosensor 12 and interface pads 14P for carrying the signal.
- the X length of the body may be from about 0.3 mm to about 2 mm, and the Y width of the body may be from about 0.3 mm to about 2 mm. Smaller body dimensions permit higher wafer density of microprobe devices (acreage) during manufacture.
- the biosensor is positioned on the microprobe sufficiently distant from the body end to pass into the subject during penetration. Positioning the biosensor ex vivo affords greater flexibility in reagent selection.
- in vivo biosensor 12 is positioned on microprobe 16 near penetration end 16P.
- the biosensor accesses the analyte fluid by penetrating into the subject and contacting the fluid.
- the analyte fluid may be any suitable body fluid such as blood, serum, or interstitial fluid or intracellular fluid.
- the in vivo biosensor is located sufficiently back from the penetration end of the microprobe so as not to affect the sharpness of the point or interfere with penetration of the probe. Access may be assisted by fluid seepage along the microspace between probe and tissue up the side of the probe from the tip to the biosensor.
- Diabetes monitoring is the primary focus of this disclosure for illustrative purposes.
- the microprobe device has uses in the diagnostic procedures and treatment of other diseases, emergency room status monitoring, sports medicine, veterinary medicine, research and development, with human subjects or experimental animals.
- the microprobe may be width tapered along the X length dimension, converging from a larger Y width dimension (of about 200 micrometers) at the body end to a smaller Y width dimension (of about 30 micrometers) at the penetration end.
- the X length of the microprobe may be from about 0.5 mm to about 2.5 mm with a penetration depth of from about 0.5 mm to about 2 mm.
- the discomfort or sensation experienced by the subject normally decreases with decreasing probe cross section and length. However, a sensation floor exists where sensation is so minimal that probes smaller then this floor threshold do not offer any advantage.
- the taper permits easier penetration due to the gradually increasing cross section of the probe. In addition, the taper reduces the volume of the probe causing less tissue displacement and less discomfort to the subject.
- the volume of the probe may be further reduced by thinning the Z dimension (see FIG. 3B) from the initial thickness of the silicon wafer across body 34 to a slender thickness alo ⁇ g probe 36.
- the thickness of the silicon wafer may be from about 500 micrometers (for a 4" wafer) to about 700 micrometers (for a 6" wafer) .
- Back side 30B of substrate 3OS may be etched away to about 50 micrometers to thin the Z thickness dimension of the probe.
- the convergence of the microprobe taper may be uniform (as shown in FIG. 1A) establishing a constant change in the Y width dimension and a corresponding constant decrease in the cross section of probe 16.
- the convergence of the microprobe taper may be nonuniform (as shown in FIG. 2A) establishing a continuous change in the Y width dimension.
- This smooth change in width optimizes stress distribution within microprobe 26 during penetration and reduces material failure. That is, the probe is less likely to "snap off" in the skin of the subject during use.
- the function for such a continuous change may be generated by stress analysis computer programs.
- Rounded microfillet 46F see FIGS.
- the Y width dimension of the microprobe may terminate in a suitably shaped point at the penetration end, such as symmetrically shaped point 16P (shown in FIG. 1A) or chisel shaped point 26P (shown in FIG. 2A) .
- biosensor 22 is positioned on body 24 of device 20, and does not pass into the subject during penetration.
- the biosensor may be positioned on the microprobe sufficiently close to the body end so as not to penetrate.
- the analyte fluid may be guided along microprobe 26 to biosensor 22 through a suitable conduit such as open fluid channel or groove 26G formed along the probe.
- the channel extends between the penetration end of the probe and the biosensor, and conveys the fluid by capillary action.
- the open fluid channel may be a V-groove etched in the silicon of microprobe 26-
- the minute dimensions along apex 26A of triangular groove 26G (shown in FIG. 2C cross section view) produce strong capillary forces that are more reliable than fluid seepage.
- the width and depth of V-grooves may be precisely controlled by V-groove etching IC technology.
- other channel cross sections may be produced by other techniques such as plasma etching.
- the biosensor may be an electrotype biosensor (see FIG. 1A) , in which the signal is electrical energy carried on electrically conductive leads 12L and interface pads 14P. More specifically, the biosensor may be an electrochemical biosensor responsive to the analyte presence by altering the electrical energy of the signal in proportion to the concentration of the analyte presence.
- the analyte signal may be voltage based or current based, and may be a modulation of a quiescent value.
- the biosensor may be an oscillating electrogravimetric biosensor responsive to the analyte presence by altering the oscillation frequency. The magnitude of the alteration in frequency indicates the concentration of the analyte presence, and may be a.c.
- the biosensor may be a thermal biosensor which senses heat generated in an analyte reaction, or an optical biosensor 42 (see FIG. 4A) which senses reaction light.
- the light signal alterations are photon energy propagating along optrode signal carrier 42W which widens into optical coupler 42C for interfacing with a meter (not shown) .
- the optrode may be any suitable photon containment device such as a waveguide or optical fiber transparent at the photon wavelength.
- the biosensor may be self-luminescent or merely return incident interrogation light.
- the biosensor may be integrated into the surface of the substrate, or housed in a cavity formed in the substrate or in a hole extending through the substrate.
- the surface of side 10A of silicon substrate 10S is planar (see FIG. IB), and biosensor 12 is deposited onto this flat surface.
- Cavity 20C (see in FIG. 2B) is etched into side 20A of silicon substrate 20S. Cavity 20C extends into the silicon substrate in the Z thickness dimension.
- the biosensor is deposited onto the silicon within the cavity.
- Hole 40H (see FIG. 4B) is etched into side 40A of silicon substrate 40S. Hole 40H extends through the silicon substrate in the Z thickness dimension.
- the electrotype biosensor may have a suitable electrically insulative layer such as silicon oxide film 10F (see FIG. 1A) on side 10A between conductive leads 12L and silicon substrate 10S. Silicon oxide is a better insulator than silicon, and may be employed to reduce shunt signal loss between the signal leads.
- Biosensor 12 is deposited on the insulative layer and is electrically isolated from the silicon substrate.
- the conductive leads and the conductive contacts of the electrotype biosensors may be a suitably conductive material also deposited on the insulative layer such as metal (sputtered Al Au Ti Ag W or Cr for example) or carbon or doped silicon.
- Doped silicon leads may have a customized electrical resistance (and other characteristics) to optimize electrical features such as impedance matching or current limiting.
- the silicon substrate may also be sufficiently doped to form the conductive material for one of the pair of conductive leads and one of the pair of conductive contacts (see FIG. 3A) .
- biosensors may be employed on a single probe. Each of these multiple biosensors may sense the presence of a different analyte. Further, each of the multiple biosensors may be positioned at a different location along the X dimension of microprobe 36 to sense analyte presence at a different penetration depth (deep, medium, and shallow) . In other embodiments, multiple biosensors may sense the same analyte at different depths, or sense different analytes at the same depth. For example (see FIGS. 3A and 3B) , three biosensors 32D (deep) , 32M (medium) , and 32S (shallow) may be deposited onto side 30A of silicon substrate 30S.
- Silicon substrate 3OS is conductive and forms common return conductive path 30C (or ground) cooperating with conductive leads 33D, 33 , and 33S and interface contacts 34D, 34 , and 34S.
- the return conductive path completes the electric circuit from the biosensors 32D, 32M, and 32S to an external meter and back to the biosensors.
- Silicon oxide layer 30F insulates the conductive return path from the source paths and source pads .
- Biosensor 32S is located on back side 30B on insulating layer 3IF, with conductive lead 33S extending though layer 3IF and substrate 30S and layer 30F to front side 30A.
- TRANSMITTER EMBODIMENT (FIGS. 5A and 5B)
- Microprobe device 50M may be sealed within a housing or cover 58C with signal transmitter 54T forming monitoring assembly 50A as shown in FIGS. 5A and 5B.
- the assembly is emplaced at a suitable site on the subject (not shown) for continuous monitoring of the analyte .
- Analyte data may be transmitted during an extended monitoring period of a few hours or several days or even weeks. Alternatively, the monitoring may be for a short period or even for a single transmission.
- the assembly transmits analyte concentration data to a remote meter (not shown) .
- the emplacement site is not subject to disturbance by daily activity of the subject.
- the inside of the subject's arm is a convenient protected site.
- Microprobe portion 56 penetrates into the subject to access the analyte-containing fluid.
- Biosensor 52 on the microprobe senses analyte presence and provides a sensed signal in response to the analyte presence .
- Base 58B extends in the Y dimension and Z dimension generally normal to the X dimension of microprobe portion 56, and forms the bottom of the assembly.
- Cover 58C is installed over body portion 54 of the substrate and engages base 58B for sealing the assembly.
- Stabilizing surface 58S forms an in vivo face of base member 58B and disposed toward the subject when emplaced. The stabilizing surface engages the subject to maintain the penetration orientation of the microprobe portion into the subject.
- the stabilizing surface may have adhesive film 58A thereon for retaining the assembly at the emplacement site for the duration of the monitoring period. The adhesive holds the assembly onto the skin preventing displacement along the X dimension. The adhesive prevents the probe from working loose during the monitoring period as the subject moves around.
- the adhesive prevents lateral displacement of the assembly along the Y and Z dimensions. This lateral retention minimizes shear forces along the length of probe 56 preventing the probe from snapping off during subject activity. As the assembly is emplaced, the stabilizing surface engages the subject's skin and limits the penetration of the microprobe portion.
- Signal transmitter 54T provides a transmitted analyte signal to a meter (not shown) .
- Analog to digital converter 54A converts the sensed signal from the biosensor into a digital transmitted signal.
- a suitable power source such as battery 54B may be provided to activate the signal transmitter and the converter.
- the transmitter, converter and battery may be deposited into the silicon of body portion 54.
- Fig. 6 shows the averaged response from 62 patients in a clinical trial to determine the relative pain perceived from punctures with a silicon microprobe in the arm compared with punctures in the arm and finger with conventional metal lancets.
- the punctures from the silicon microprobe were found to be noticeably less painful than those from the lancet, with the more painful of the two lancet tests being the finger stick, as expected.
- the test subjects repeatedly commented that the microprobe puncture was virtually painless and far more comfortable than the finger stick with the lancet.
- microprobe device with integrated analyte sensing capability, which accesses the blood and determines the analyte concentration in one simple step.
- the device is fabricated from a silicon wafer for compatibility with IC fabrication and MEMS technologies. Because the strength of the single-crystal structure of the starting silicon wafer is retained in the finished device, the microprobe can penetrate skin reliably without breaking. The small length, width, and thickness dimensions of the probe introduce minimal tissue displacement, rendering probe insertion and retraction essentially painless. Minimal penetration effort is required which also minimizes mechanical probe failure .
- the device may function in vivo or ex vivo with one or multiple biosensors, and has both single measurement and continuous monitoring applications .
- biosensors may be employed in either the ex vivo embodiment (FIG. 2A) or the in vivo embodiment (FIG. 1A) .
- the stress reducing microfillet shown in the optical biosensor embodiment (FIG. 4A) may be employed in other types of biosensors.
- the cavity housing (FIG. 2B) and hole housing (FIG. 4B) of the biosensor may be employed in other embodiments.
- features of embodiments shown in various figures may be employed in combination with embodiments shown in other figures. Therefore, the scope of the invention is to be determined by the terminology of the following claims and the legal equivalents thereof.
Abstract
Description
Claims
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2002255910A AU2002255910A1 (en) | 2001-03-26 | 2002-03-26 | Silicon microprobe with integrated biosensor for measuring glucose content in blood |
EP02725341A EP1379165A2 (en) | 2001-03-26 | 2002-03-26 | Silicon microprobe with integrated biosensor for measuring glucose content in blood |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/816,472 | 2001-03-26 | ||
US09/816,472 US7310543B2 (en) | 2001-03-26 | 2001-03-26 | Silicon microprobe with integrated biosensor |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2002077638A2 true WO2002077638A2 (en) | 2002-10-03 |
WO2002077638A3 WO2002077638A3 (en) | 2003-02-27 |
Family
ID=25220711
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2002/009163 WO2002077638A2 (en) | 2001-03-26 | 2002-03-26 | Silicon microprobe with integrated biosensor for measuring glucose content in blood |
Country Status (4)
Country | Link |
---|---|
US (3) | US7310543B2 (en) |
EP (1) | EP1379165A2 (en) |
AU (1) | AU2002255910A1 (en) |
WO (1) | WO2002077638A2 (en) |
Cited By (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7648468B2 (en) | 2002-04-19 | 2010-01-19 | Pelikon Technologies, Inc. | Method and apparatus for penetrating tissue |
US7674232B2 (en) | 2002-04-19 | 2010-03-09 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7708701B2 (en) | 2002-04-19 | 2010-05-04 | Pelikan Technologies, Inc. | Method and apparatus for a multi-use body fluid sampling device |
US7717863B2 (en) | 2002-04-19 | 2010-05-18 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7901362B2 (en) | 2002-04-19 | 2011-03-08 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US8087141B2 (en) | 2004-12-17 | 2012-01-03 | Roche Diagnostics Operations, Inc. | Method for producing a pricking element |
US8267870B2 (en) | 2002-04-19 | 2012-09-18 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for body fluid sampling with hybrid actuation |
US9034639B2 (en) | 2002-12-30 | 2015-05-19 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus using optical techniques to measure analyte levels |
US9072842B2 (en) | 2002-04-19 | 2015-07-07 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
US9089294B2 (en) | 2002-04-19 | 2015-07-28 | Sanofi-Aventis Deutschland Gmbh | Analyte measurement device with a single shot actuator |
US9248267B2 (en) | 2002-04-19 | 2016-02-02 | Sanofi-Aventis Deustchland Gmbh | Tissue penetration device |
US9261476B2 (en) | 2004-05-20 | 2016-02-16 | Sanofi Sa | Printable hydrogel for biosensors |
US9295393B2 (en) | 2012-11-09 | 2016-03-29 | Elwha Llc | Embolism deflector |
US9427532B2 (en) | 2001-06-12 | 2016-08-30 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
US9561000B2 (en) | 2003-12-31 | 2017-02-07 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for improving fluidic flow and sample capture |
US9560993B2 (en) | 2001-11-21 | 2017-02-07 | Sanofi-Aventis Deutschland Gmbh | Blood testing apparatus having a rotatable cartridge with multiple lancing elements and testing means |
US9694144B2 (en) | 2001-06-12 | 2017-07-04 | Sanofi-Aventis Deutschland Gmbh | Sampling module device and method |
US9724021B2 (en) | 2002-04-19 | 2017-08-08 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
US9795747B2 (en) | 2010-06-02 | 2017-10-24 | Sanofi-Aventis Deutschland Gmbh | Methods and apparatus for lancet actuation |
US9820684B2 (en) | 2004-06-03 | 2017-11-21 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for a fluid sampling device |
US9839386B2 (en) | 2002-04-19 | 2017-12-12 | Sanofi-Aventis Deustschland Gmbh | Body fluid sampling device with capacitive sensor |
US10034628B2 (en) | 2003-06-11 | 2018-07-31 | Sanofi-Aventis Deutschland Gmbh | Low pain penetrating member |
Families Citing this family (92)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6036924A (en) | 1997-12-04 | 2000-03-14 | Hewlett-Packard Company | Cassette of lancet cartridges for sampling blood |
US6391005B1 (en) | 1998-03-30 | 2002-05-21 | Agilent Technologies, Inc. | Apparatus and method for penetration with shaft having a sensor for sensing penetration depth |
DE10057832C1 (en) * | 2000-11-21 | 2002-02-21 | Hartmann Paul Ag | Blood analysis device has syringe mounted in casing, annular mounting carrying needles mounted behind test strip and being swiveled so that needle can be pushed through strip and aperture in casing to take blood sample |
US7144495B2 (en) * | 2000-12-13 | 2006-12-05 | Lifescan, Inc. | Electrochemical test strip with an integrated micro-needle and associated methods |
CN1525834A (en) | 2001-01-22 | 2004-09-01 | - | Lancet device having capillary action |
JP4272051B2 (en) | 2001-06-12 | 2009-06-03 | ペリカン テクノロジーズ インコーポレイテッド | Blood sampling apparatus and method |
WO2002100254A2 (en) | 2001-06-12 | 2002-12-19 | Pelikan Technologies, Inc. | Method and apparatus for lancet launching device integrated onto a blood-sampling cartridge |
ES2336081T3 (en) | 2001-06-12 | 2010-04-08 | Pelikan Technologies Inc. | SELF-OPTIMIZATION PUNCTURE DEVICE WITH MEANS OF ADAPTATION TO TEMPORARY VARIATIONS IN CUTANEOUS PROPERTIES. |
US8337419B2 (en) | 2002-04-19 | 2012-12-25 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
US7981056B2 (en) | 2002-04-19 | 2011-07-19 | Pelikan Technologies, Inc. | Methods and apparatus for lancet actuation |
DE60238119D1 (en) | 2001-06-12 | 2010-12-09 | Pelikan Technologies Inc | ELECTRIC ACTUATOR ELEMENT FOR A LANZETTE |
EP1404234B1 (en) | 2001-06-12 | 2011-02-09 | Pelikan Technologies Inc. | Apparatus for improving success rate of blood yield from a fingerstick |
US9226699B2 (en) | 2002-04-19 | 2016-01-05 | Sanofi-Aventis Deutschland Gmbh | Body fluid sampling module with a continuous compression tissue interface surface |
US6749792B2 (en) * | 2001-07-09 | 2004-06-15 | Lifescan, Inc. | Micro-needles and methods of manufacture and use thereof |
DE10134650B4 (en) | 2001-07-20 | 2009-12-03 | Roche Diagnostics Gmbh | System for taking small amounts of body fluid |
US7004928B2 (en) | 2002-02-08 | 2006-02-28 | Rosedale Medical, Inc. | Autonomous, ambulatory analyte monitor or drug delivery device |
US7371247B2 (en) | 2002-04-19 | 2008-05-13 | Pelikan Technologies, Inc | Method and apparatus for penetrating tissue |
US7232451B2 (en) | 2002-04-19 | 2007-06-19 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US8360992B2 (en) | 2002-04-19 | 2013-01-29 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
US7892183B2 (en) | 2002-04-19 | 2011-02-22 | Pelikan Technologies, Inc. | Method and apparatus for body fluid sampling and analyte sensing |
US7976476B2 (en) | 2002-04-19 | 2011-07-12 | Pelikan Technologies, Inc. | Device and method for variable speed lancet |
US8372016B2 (en) | 2002-04-19 | 2013-02-12 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for body fluid sampling and analyte sensing |
US7175642B2 (en) | 2002-04-19 | 2007-02-13 | Pelikan Technologies, Inc. | Methods and apparatus for lancet actuation |
US7297122B2 (en) | 2002-04-19 | 2007-11-20 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US8221334B2 (en) | 2002-04-19 | 2012-07-17 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
US7291117B2 (en) | 2002-04-19 | 2007-11-06 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7491178B2 (en) | 2002-04-19 | 2009-02-17 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7547287B2 (en) | 2002-04-19 | 2009-06-16 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7229458B2 (en) | 2002-04-19 | 2007-06-12 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7909778B2 (en) | 2002-04-19 | 2011-03-22 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US9314194B2 (en) | 2002-04-19 | 2016-04-19 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
US7331931B2 (en) | 2002-04-19 | 2008-02-19 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7343188B2 (en) * | 2002-05-09 | 2008-03-11 | Lifescan, Inc. | Devices and methods for accessing and analyzing physiological fluid |
US7060192B2 (en) * | 2002-05-09 | 2006-06-13 | Lifescan, Inc. | Methods of fabricating physiological sample collection devices |
CA2444211C (en) * | 2002-10-11 | 2013-11-19 | Dermal Therapy (Barbados) Inc. | Determination of biological conditions using impedance measurements |
US7815579B2 (en) * | 2005-03-02 | 2010-10-19 | Roche Diagnostics Operations, Inc. | Dynamic integrated lancing test strip with sterility cover |
US7214200B2 (en) | 2002-12-30 | 2007-05-08 | Roche Diagnostics Operations, Inc. | Integrated analytical test element |
US7052652B2 (en) | 2003-03-24 | 2006-05-30 | Rosedale Medical, Inc. | Analyte concentration detection devices and methods |
AU2004231988B2 (en) * | 2003-04-16 | 2010-04-15 | Drexel University | Acoustic blood analyzer for assessing blood properties |
ATE476137T1 (en) | 2003-05-30 | 2010-08-15 | Pelikan Technologies Inc | METHOD AND DEVICE FOR INJECTING LIQUID |
DK1633235T3 (en) | 2003-06-06 | 2014-08-18 | Sanofi Aventis Deutschland | Apparatus for sampling body fluid and detecting analyte |
US7146202B2 (en) | 2003-06-16 | 2006-12-05 | Isense Corporation | Compound material analyte sensor |
US20050059166A1 (en) * | 2003-09-11 | 2005-03-17 | Robert Markes | Sampling instrument |
EP1671096A4 (en) | 2003-09-29 | 2009-09-16 | Pelikan Technologies Inc | Method and apparatus for an improved sample capture device |
EP1680014A4 (en) | 2003-10-14 | 2009-01-21 | Pelikan Technologies Inc | Method and apparatus for a variable user interface |
US8224410B2 (en) * | 2003-12-22 | 2012-07-17 | Hadvary Paul | Dermally affixed sensor device |
US7822454B1 (en) | 2005-01-03 | 2010-10-26 | Pelikan Technologies, Inc. | Fluid sampling device with improved analyte detecting member configuration |
US9775553B2 (en) | 2004-06-03 | 2017-10-03 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for a fluid sampling device |
US20060030788A1 (en) * | 2004-08-04 | 2006-02-09 | Daniel Wong | Apparatus and method for extracting bodily fluid utilizing a flat lancet |
EP1627684A1 (en) * | 2004-08-20 | 2006-02-22 | F. Hoffmann-La Roche Ag | Microfluidic system and method of producing the same |
US7488298B2 (en) * | 2004-10-08 | 2009-02-10 | Roche Diagnostics Operations, Inc. | Integrated lancing test strip with capillary transfer sheet |
US8652831B2 (en) | 2004-12-30 | 2014-02-18 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for analyte measurement test time |
US7935063B2 (en) * | 2005-03-02 | 2011-05-03 | Roche Diagnostics Operations, Inc. | System and method for breaking a sterility seal to engage a lancet |
US20060264716A1 (en) * | 2005-04-25 | 2006-11-23 | Dennis Zander | Microneedle with glucose sensor and methods thereof |
US20060281187A1 (en) | 2005-06-13 | 2006-12-14 | Rosedale Medical, Inc. | Analyte detection devices and methods with hematocrit/volume correction and feedback control |
EP1733676B1 (en) * | 2005-06-17 | 2012-08-01 | F. Hoffmann-La Roche AG | Sensor system, arrangement and method for monitoring a compound, in particular glucose in body tissue. |
US8382681B2 (en) | 2005-09-30 | 2013-02-26 | Intuity Medical, Inc. | Fully integrated wearable or handheld monitor |
US8801631B2 (en) | 2005-09-30 | 2014-08-12 | Intuity Medical, Inc. | Devices and methods for facilitating fluid transport |
WO2007045412A1 (en) * | 2005-10-15 | 2007-04-26 | F. Hoffmann-La Roche Ag | Test element and test system for examining a body fluid |
EP1911394B1 (en) * | 2006-10-14 | 2009-05-06 | Roche Diagnostics GmbH | Lancet with capillar channel |
US20080275326A1 (en) * | 2007-05-01 | 2008-11-06 | Joachim Kasielke | Sensor for monitoring a condition of a patient |
US7766846B2 (en) | 2008-01-28 | 2010-08-03 | Roche Diagnostics Operations, Inc. | Rapid blood expression and sampling |
JP2011511665A (en) * | 2008-02-04 | 2011-04-14 | バイエル・ヘルスケア・エルエルシー | Analyte sensor and method using semiconductors |
WO2009126900A1 (en) | 2008-04-11 | 2009-10-15 | Pelikan Technologies, Inc. | Method and apparatus for analyte detecting device |
FR2930423B1 (en) * | 2008-04-25 | 2010-05-07 | Gerard Scortecci | DEVICE FOR BONE REGENERATION |
CA2725264C (en) | 2008-05-30 | 2017-06-20 | Intuity Medical, Inc. | Body fluid sampling device -- sampling site interface |
WO2009149197A2 (en) * | 2008-06-03 | 2009-12-10 | University Of Utah Research Foundation | High aspect ratio microelectrode arrays enabled to have customizable lengths and methods of making the same |
EP2299904B1 (en) | 2008-06-06 | 2019-09-11 | Intuity Medical, Inc. | Medical measurement method |
US9636051B2 (en) | 2008-06-06 | 2017-05-02 | Intuity Medical, Inc. | Detection meter and mode of operation |
CA2735666A1 (en) | 2008-09-19 | 2010-03-25 | Bayer Healthcare Llc | Analyte sensors, testing apparatus and manufacturing methods |
CN102171557B (en) | 2008-09-19 | 2016-10-19 | 安晟信医疗科技控股公司 | There is electrochemical appliance and the manufacture method thereof of the electro-chemical activity of enhancing |
US9173597B2 (en) * | 2008-09-19 | 2015-11-03 | Bayer Healthcare Llc | Analyte sensors, systems, testing apparatus and manufacturing methods |
EP2341828A4 (en) * | 2008-09-19 | 2012-11-21 | Bayer Healthcare Llc | Lancet analyte sensors and methods of manufacturing |
US9375169B2 (en) | 2009-01-30 | 2016-06-28 | Sanofi-Aventis Deutschland Gmbh | Cam drive for managing disposable penetrating member actions with a single motor and motor and control system |
EP2482724A2 (en) | 2009-09-30 | 2012-08-08 | Dexcom, Inc. | Transcutaneous analyte sensor |
WO2011065981A1 (en) | 2009-11-30 | 2011-06-03 | Intuity Medical, Inc. | Calibration material delivery devices and methods |
US8965476B2 (en) | 2010-04-16 | 2015-02-24 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
US10330667B2 (en) | 2010-06-25 | 2019-06-25 | Intuity Medical, Inc. | Analyte monitoring methods and systems |
JP5044685B2 (en) * | 2010-09-10 | 2012-10-10 | 株式会社東芝 | Microprobe, recording apparatus, and method of manufacturing microprobe |
WO2012075331A2 (en) * | 2010-12-01 | 2012-06-07 | Pinnacle Technology, Inc. | Tissue implantable microbiosensor |
JP6223337B2 (en) | 2011-08-03 | 2017-11-08 | インテュイティ メディカル インコーポレイテッド | Body fluid extraction measuring instrument |
US20140107450A1 (en) | 2012-10-12 | 2014-04-17 | Dexcom, Inc. | Sensors for continuous analyte monitoring, and related methods |
US20140213866A1 (en) | 2012-10-12 | 2014-07-31 | Dexcom, Inc. | Sensors for continuous analyte monitoring, and related methods |
WO2014088492A1 (en) * | 2012-12-07 | 2014-06-12 | Ascilion Ab | A microfabricated sensor and a method of sensing the level of a component in bodily fluid |
WO2014205412A1 (en) | 2013-06-21 | 2014-12-24 | Intuity Medical, Inc. | Analyte monitoring system with audible feedback |
US20150289788A1 (en) | 2014-04-10 | 2015-10-15 | Dexcom, Inc. | Sensors for continuous analyte monitoring, and related methods |
US9958444B2 (en) * | 2014-05-30 | 2018-05-01 | Sober stearing Sensors Canada, Inc. | Apparatus, systems and methods for sensing an analyte such as ethanol |
CN107148644B (en) * | 2014-10-30 | 2020-04-03 | 富士胶片株式会社 | Sensor device and sensor system |
US20180263539A1 (en) * | 2015-09-28 | 2018-09-20 | The Regents Of The University Of California | Wearable sensor arrays for in-situ body fluid analysis |
TWI593964B (en) * | 2016-08-26 | 2017-08-01 | 超極生技股份有限公司 | Probe type detecting device and module |
US20180075267A1 (en) | 2016-09-11 | 2018-03-15 | Verily Life Sciences Llc | System of injectable fully-monolithic wireless bio-sensing |
CN111582128B (en) * | 2020-04-30 | 2022-05-03 | 电子科技大学 | Mechanical fault sparse representation method based on wolf pack parameterized joint dictionary |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5591139A (en) * | 1994-06-06 | 1997-01-07 | The Regents Of The University Of California | IC-processed microneedles |
US5801057A (en) * | 1996-03-22 | 1998-09-01 | Smart; Wilson H. | Microsampling device and method of construction |
US5928207A (en) * | 1997-06-30 | 1999-07-27 | The Regents Of The University Of California | Microneedle with isotropically etched tip, and method of fabricating such a device |
US6106751A (en) * | 1998-03-18 | 2000-08-22 | The Regents Of The University Of California | Method for fabricating needles via conformal deposition in two-piece molds |
WO2001093930A1 (en) * | 2000-06-02 | 2001-12-13 | The University Of Utah Research Foundation | Active needle devices with integrated functionality |
Family Cites Families (89)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB309294A (en) | 1928-03-29 | 1929-04-11 | Ml Magneto Syndicate Ltd | Improvements relating to dynamo electric machines |
US2359550A (en) | 1942-07-07 | 1944-10-03 | Salsbury S Lab Dr | Fowl vaccinator |
US3046987A (en) | 1957-06-05 | 1962-07-31 | Joseph C Ehrlich | Disposable lancet |
US3640267A (en) | 1969-12-15 | 1972-02-08 | Damon Corp | Clinical sample container |
US3640388A (en) | 1970-08-20 | 1972-02-08 | Damon Corp | Dialyzing liquid-collecting container |
US3799742A (en) | 1971-12-20 | 1974-03-26 | C Coleman | Miniaturized integrated analytical test container |
CA1226036A (en) | 1983-05-05 | 1987-08-25 | Irving J. Higgins | Analytical equipment and sensor electrodes therefor |
US4627445A (en) | 1985-04-08 | 1986-12-09 | Garid, Inc. | Glucose medical monitoring system |
DE3515420A1 (en) | 1985-04-29 | 1986-10-30 | Fischer, Artur, Dr.H.C., 7244 Waldachtal | Blood glucose testing unit |
FR2590673B1 (en) | 1985-11-05 | 1988-09-16 | Bally Philippe | SELF-CONTAINED MINIATURIZED TEST DEVICE FOR SINGLE USE |
US4837049A (en) | 1986-06-17 | 1989-06-06 | Alfred E. Mann Foundation For Scientific Research | Method of making an electrode array |
US4873993A (en) | 1986-07-22 | 1989-10-17 | Personal Diagnostics, Inc. | Cuvette |
US5029583A (en) | 1986-07-22 | 1991-07-09 | Personal Diagnostics, Inc. | Optical analyzer |
US4790979A (en) | 1986-08-29 | 1988-12-13 | Technimed Corporation | Test strip and fixture |
US5014718A (en) | 1988-01-22 | 1991-05-14 | Safety Diagnostics, Inc. | Blood collection and testing method |
US4995402A (en) | 1988-10-12 | 1991-02-26 | Thorne, Smith, Astill Technologies, Inc. | Medical droplet whole blood and like monitoring |
US5035704A (en) | 1989-03-07 | 1991-07-30 | Lambert Robert D | Blood sampling mechanism |
US5054499A (en) | 1989-03-27 | 1991-10-08 | Swierczek Remi D | Disposable skin perforator and blood testing device |
GB8911462D0 (en) | 1989-05-18 | 1989-07-05 | Ares Serono Res & Dev Ltd | Devices for use in chemical test procedures |
US5593852A (en) * | 1993-12-02 | 1997-01-14 | Heller; Adam | Subcutaneous glucose electrode |
DE69229180T2 (en) | 1991-11-12 | 1999-10-14 | Urs A Ramel | LANCETTE DEVICE |
US5231993A (en) | 1991-11-20 | 1993-08-03 | Habley Medical Technology Corporation | Blood sampler and component tester with guide member |
DE4212315A1 (en) | 1992-04-13 | 1993-10-14 | Boehringer Mannheim Gmbh | Blood lancet device for drawing blood for diagnostic purposes |
US5217480A (en) | 1992-06-09 | 1993-06-08 | Habley Medical Technology Corporation | Capillary blood drawing device |
US5290420A (en) | 1992-08-12 | 1994-03-01 | Esa, Inc. | Sampling system and analysis cell for stripping voltammetry |
US5582184A (en) | 1993-10-13 | 1996-12-10 | Integ Incorporated | Interstitial fluid collection and constituent measurement |
US5497772A (en) | 1993-11-19 | 1996-03-12 | Alfred E. Mann Foundation For Scientific Research | Glucose monitoring system |
US5824473A (en) * | 1993-12-10 | 1998-10-20 | California Institute Of Technology | Nucleic acid mediated electron transfer |
US5513636A (en) * | 1994-08-12 | 1996-05-07 | Cb-Carmel Biotechnology Ltd. | Implantable sensor chip |
US5514152A (en) | 1994-08-16 | 1996-05-07 | Specialized Health Products, Inc. | Multiple segment encapsulated medical lancing device |
US5636640A (en) | 1995-02-06 | 1997-06-10 | Volunteers For Medical Engineering | Liquid sampling and test apparatus |
US5568806A (en) * | 1995-02-16 | 1996-10-29 | Minimed Inc. | Transcutaneous sensor insertion set |
US5682233A (en) | 1995-09-08 | 1997-10-28 | Integ, Inc. | Interstitial fluid sampler |
AU7015096A (en) | 1995-09-08 | 1997-04-09 | Integ, Inc. | Body fluid sampler |
US6001307A (en) | 1996-04-26 | 1999-12-14 | Kyoto Daiichi Kagaku Co., Ltd. | Device for analyzing a sample |
ES2121565B1 (en) | 1996-05-17 | 2000-12-16 | Mercury Diagnostics Inc | DISPOSABLE ITEM FOR USE IN A BODY FLUID SAMPLING DEVICE. |
US6332871B1 (en) | 1996-05-17 | 2001-12-25 | Amira Medical | Blood and interstitial fluid sampling device |
ATE286252T1 (en) | 1996-10-25 | 2005-01-15 | Idexx Lab Inc | IMMUNOASSAY DEVICE WITH A DIVISABLE HOUSING |
US6071251A (en) | 1996-12-06 | 2000-06-06 | Abbott Laboratories | Method and apparatus for obtaining blood for diagnostic tests |
US6063039A (en) | 1996-12-06 | 2000-05-16 | Abbott Laboratories | Method and apparatus for obtaining blood for diagnostic tests |
ATE227844T1 (en) | 1997-02-06 | 2002-11-15 | Therasense Inc | SMALL VOLUME SENSOR FOR IN-VITRO DETERMINATION |
DE69823904T2 (en) * | 1997-03-20 | 2005-06-16 | F. Hoffmann-La Roche Ag | Micromechanical pipetting device |
US6259937B1 (en) | 1997-09-12 | 2001-07-10 | Alfred E. Mann Foundation | Implantable substrate sensor |
US5938679A (en) | 1997-10-14 | 1999-08-17 | Hewlett-Packard Company | Apparatus and method for minimally invasive blood sampling |
DE19753847A1 (en) | 1997-12-04 | 1999-06-10 | Roche Diagnostics Gmbh | Analytical test element with capillary channel |
US5871494A (en) | 1997-12-04 | 1999-02-16 | Hewlett-Packard Company | Reproducible lancing for sampling blood |
DE19753849A1 (en) | 1997-12-04 | 1999-06-10 | Roche Diagnostics Gmbh | Analytical test element with a tapered capillary channel |
JP3978489B2 (en) * | 1998-02-26 | 2007-09-19 | アークレイ株式会社 | Blood measuring device |
US6134461A (en) * | 1998-03-04 | 2000-10-17 | E. Heller & Company | Electrochemical analyte |
US6091975A (en) * | 1998-04-01 | 2000-07-18 | Alza Corporation | Minimally invasive detecting device |
JP3398598B2 (en) | 1998-06-10 | 2003-04-21 | 松下電器産業株式会社 | Substrate quantification method and analytical element and measuring device used for the method |
US6503231B1 (en) * | 1998-06-10 | 2003-01-07 | Georgia Tech Research Corporation | Microneedle device for transport of molecules across tissue |
US6201980B1 (en) | 1998-10-05 | 2001-03-13 | The Regents Of The University Of California | Implantable medical sensor system |
US6360888B1 (en) | 1999-02-25 | 2002-03-26 | Minimed Inc. | Glucose sensor package system |
US7077828B2 (en) | 1999-03-05 | 2006-07-18 | Roche Diagnostics Gmbh | Device for withdrawing blood for diagnostic applications |
DE19909602A1 (en) | 1999-03-05 | 2000-09-07 | Roche Diagnostics Gmbh | Device for drawing blood for diagnostic purposes |
US6132449A (en) | 1999-03-08 | 2000-10-17 | Agilent Technologies, Inc. | Extraction and transportation of blood for analysis |
US6375627B1 (en) | 2000-03-02 | 2002-04-23 | Agilent Technologies, Inc. | Physiological fluid extraction with rapid analysis |
DE10010587A1 (en) | 2000-03-03 | 2001-09-06 | Roche Diagnostics Gmbh | System for the determination of analyte concentrations in body fluids |
US6405066B1 (en) | 2000-03-17 | 2002-06-11 | The Regents Of The University Of California | Implantable analyte sensor |
US6612111B1 (en) * | 2000-03-27 | 2003-09-02 | Lifescan, Inc. | Method and device for sampling and analyzing interstitial fluid and whole blood samples |
US6442413B1 (en) | 2000-05-15 | 2002-08-27 | James H. Silver | Implantable sensor |
US6561989B2 (en) | 2000-07-10 | 2003-05-13 | Bayer Healthcare, Llc | Thin lance and test sensor having same |
US6358265B1 (en) | 2000-07-18 | 2002-03-19 | Specialized Health Products, Inc. | Single-step disposable safety lancet apparatus and methods |
GB0030929D0 (en) | 2000-12-19 | 2001-01-31 | Inverness Medical Ltd | Analyte measurement |
US7691071B2 (en) | 2001-01-19 | 2010-04-06 | Panasonic Corporation | Lancet-integrated sensor, measurer for lancet-integrated sensor, and cartridge |
CN1525834A (en) | 2001-01-22 | 2004-09-01 | - | Lancet device having capillary action |
US6783502B2 (en) | 2001-04-26 | 2004-08-31 | Phoenix Bioscience | Integrated lancing and analytic device |
DE10134650B4 (en) | 2001-07-20 | 2009-12-03 | Roche Diagnostics Gmbh | System for taking small amounts of body fluid |
US20030028087A1 (en) | 2001-08-01 | 2003-02-06 | Yuzhakov Vadim Vladimirovich | Devices for analyte concentration determination and methods of using the same |
US20030028125A1 (en) | 2001-08-06 | 2003-02-06 | Yuzhakov Vadim V. | Physiological sample collection devices and methods of using the same |
DE10142232B4 (en) | 2001-08-29 | 2021-04-29 | Roche Diabetes Care Gmbh | Process for the production of an analytical aid with a lancet and test element |
CA2419200C (en) | 2002-03-05 | 2015-06-30 | Bayer Healthcare Llc | Fluid collection apparatus having an integrated lance and reaction area |
US7343188B2 (en) | 2002-05-09 | 2008-03-11 | Lifescan, Inc. | Devices and methods for accessing and analyzing physiological fluid |
US7060192B2 (en) | 2002-05-09 | 2006-06-13 | Lifescan, Inc. | Methods of fabricating physiological sample collection devices |
US20030211619A1 (en) | 2002-05-09 | 2003-11-13 | Lorin Olson | Continuous strip of fluid sampling and testing devices and methods of making, packaging and using the same |
US7303726B2 (en) | 2002-05-09 | 2007-12-04 | Lifescan, Inc. | Minimal procedure analyte test system |
US20030143113A2 (en) | 2002-05-09 | 2003-07-31 | Lifescan, Inc. | Physiological sample collection devices and methods of using the same |
US20030212344A1 (en) | 2002-05-09 | 2003-11-13 | Vadim Yuzhakov | Physiological sample collection devices and methods of using the same |
US20030223906A1 (en) | 2002-06-03 | 2003-12-04 | Mcallister Devin | Test strip container system |
NZ526334A (en) | 2002-06-25 | 2003-10-31 | Bayer Healthcare Llc | Sensor with integrated lancet for monitoring blood by colorometric or electrochemical test method |
US7244264B2 (en) | 2002-12-03 | 2007-07-17 | Roche Diagnostics Operations, Inc. | Dual blade lancing test strip |
US20040127818A1 (en) | 2002-12-27 | 2004-07-01 | Roe Steven N. | Precision depth control lancing tip |
DE60329712D1 (en) | 2002-12-30 | 2009-11-26 | Hoffmann La Roche | BLOOD AQUISITION SUSPENSION SYSTEM |
US7374546B2 (en) | 2003-01-29 | 2008-05-20 | Roche Diagnostics Operations, Inc. | Integrated lancing test strip |
US20040193072A1 (en) | 2003-03-28 | 2004-09-30 | Allen John J. | Method of analyte measurement using integrated lance and strip |
US20040193202A1 (en) | 2003-03-28 | 2004-09-30 | Allen John J. | Integrated lance and strip for analyte measurement |
AU2004203280A1 (en) | 2003-07-28 | 2005-02-17 | Bayer Healthcare Llc | Swing Lance with Integrated Sensor |
CA2543957C (en) | 2003-10-31 | 2013-01-22 | Lifescan Scotland Limited | Method of reducing the effect of direct interference current in an electrochemical test strip |
-
2001
- 2001-03-26 US US09/816,472 patent/US7310543B2/en not_active Expired - Fee Related
-
2002
- 2002-03-26 WO PCT/US2002/009163 patent/WO2002077638A2/en not_active Application Discontinuation
- 2002-03-26 AU AU2002255910A patent/AU2002255910A1/en not_active Abandoned
- 2002-03-26 EP EP02725341A patent/EP1379165A2/en not_active Withdrawn
-
2007
- 2007-10-30 US US11/980,853 patent/US20080058624A1/en not_active Abandoned
- 2007-10-30 US US11/980,852 patent/US20080097171A1/en not_active Abandoned
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5591139A (en) * | 1994-06-06 | 1997-01-07 | The Regents Of The University Of California | IC-processed microneedles |
US5801057A (en) * | 1996-03-22 | 1998-09-01 | Smart; Wilson H. | Microsampling device and method of construction |
US5928207A (en) * | 1997-06-30 | 1999-07-27 | The Regents Of The University Of California | Microneedle with isotropically etched tip, and method of fabricating such a device |
US6106751A (en) * | 1998-03-18 | 2000-08-22 | The Regents Of The University Of California | Method for fabricating needles via conformal deposition in two-piece molds |
WO2001093930A1 (en) * | 2000-06-02 | 2001-12-13 | The University Of Utah Research Foundation | Active needle devices with integrated functionality |
Non-Patent Citations (1)
Title |
---|
SMART W H ET AL: "The use of silicon microfabrication technology in painless blood glucose monitoring." DIABETES TECHNOLOGY & THERAPEUTICS. UNITED STATES 2000 WINTER, vol. 2, no. 4, January 2000 (2000-01), pages 549-559, XP009001870 ISSN: 1520-9156 * |
Cited By (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9427532B2 (en) | 2001-06-12 | 2016-08-30 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
US9937298B2 (en) | 2001-06-12 | 2018-04-10 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
US9802007B2 (en) | 2001-06-12 | 2017-10-31 | Sanofi-Aventis Deutschland Gmbh | Methods and apparatus for lancet actuation |
US9694144B2 (en) | 2001-06-12 | 2017-07-04 | Sanofi-Aventis Deutschland Gmbh | Sampling module device and method |
US9560993B2 (en) | 2001-11-21 | 2017-02-07 | Sanofi-Aventis Deutschland Gmbh | Blood testing apparatus having a rotatable cartridge with multiple lancing elements and testing means |
US8267870B2 (en) | 2002-04-19 | 2012-09-18 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for body fluid sampling with hybrid actuation |
US9498160B2 (en) | 2002-04-19 | 2016-11-22 | Sanofi-Aventis Deutschland Gmbh | Method for penetrating tissue |
US7648468B2 (en) | 2002-04-19 | 2010-01-19 | Pelikon Technologies, Inc. | Method and apparatus for penetrating tissue |
US7674232B2 (en) | 2002-04-19 | 2010-03-09 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US9072842B2 (en) | 2002-04-19 | 2015-07-07 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
US9089678B2 (en) | 2002-04-19 | 2015-07-28 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
US9089294B2 (en) | 2002-04-19 | 2015-07-28 | Sanofi-Aventis Deutschland Gmbh | Analyte measurement device with a single shot actuator |
US9186468B2 (en) | 2002-04-19 | 2015-11-17 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
US9248267B2 (en) | 2002-04-19 | 2016-02-02 | Sanofi-Aventis Deustchland Gmbh | Tissue penetration device |
US9907502B2 (en) | 2002-04-19 | 2018-03-06 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
US9839386B2 (en) | 2002-04-19 | 2017-12-12 | Sanofi-Aventis Deustschland Gmbh | Body fluid sampling device with capacitive sensor |
US7708701B2 (en) | 2002-04-19 | 2010-05-04 | Pelikan Technologies, Inc. | Method and apparatus for a multi-use body fluid sampling device |
US7901362B2 (en) | 2002-04-19 | 2011-03-08 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US9795334B2 (en) | 2002-04-19 | 2017-10-24 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
US9724021B2 (en) | 2002-04-19 | 2017-08-08 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
US7717863B2 (en) | 2002-04-19 | 2010-05-18 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7713214B2 (en) | 2002-04-19 | 2010-05-11 | Pelikan Technologies, Inc. | Method and apparatus for a multi-use body fluid sampling device with optical analyte sensing |
US9034639B2 (en) | 2002-12-30 | 2015-05-19 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus using optical techniques to measure analyte levels |
US10034628B2 (en) | 2003-06-11 | 2018-07-31 | Sanofi-Aventis Deutschland Gmbh | Low pain penetrating member |
US9561000B2 (en) | 2003-12-31 | 2017-02-07 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for improving fluidic flow and sample capture |
US9261476B2 (en) | 2004-05-20 | 2016-02-16 | Sanofi Sa | Printable hydrogel for biosensors |
US9820684B2 (en) | 2004-06-03 | 2017-11-21 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for a fluid sampling device |
US8087141B2 (en) | 2004-12-17 | 2012-01-03 | Roche Diagnostics Operations, Inc. | Method for producing a pricking element |
US9795747B2 (en) | 2010-06-02 | 2017-10-24 | Sanofi-Aventis Deutschland Gmbh | Methods and apparatus for lancet actuation |
US9414752B2 (en) | 2012-11-09 | 2016-08-16 | Elwha Llc | Embolism deflector |
US9295393B2 (en) | 2012-11-09 | 2016-03-29 | Elwha Llc | Embolism deflector |
Also Published As
Publication number | Publication date |
---|---|
US20080097171A1 (en) | 2008-04-24 |
US20020137998A1 (en) | 2002-09-26 |
AU2002255910A1 (en) | 2002-10-08 |
US7310543B2 (en) | 2007-12-18 |
EP1379165A2 (en) | 2004-01-14 |
US20080058624A1 (en) | 2008-03-06 |
WO2002077638A3 (en) | 2003-02-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US7310543B2 (en) | Silicon microprobe with integrated biosensor | |
US6721586B2 (en) | Percutaneous biological fluid sampling and analyte measurement devices and methods | |
US6783502B2 (en) | Integrated lancing and analytic device | |
TWI234450B (en) | Biological fluid sampling and analyte measurement devices and methods | |
TW592662B (en) | Biological fluid constituent sampling and measurement devices and methods | |
AU2005220022B2 (en) | Body fluid sampling device | |
EP1997430B1 (en) | System for withdrawing body fluid | |
EP2624757B1 (en) | Diagnostic device | |
CZ20022024A3 (en) | Instrument and method for percutaneous taking a biological liquid and analyte measuring | |
PL195647B1 (en) | Method and device for sampling and analyzing interstitial fluid and whole blood samples | |
GB2154003A (en) | Diagnostic aid | |
CZ20022023A3 (en) | Percutaneous biological fluid sampling and analyte measurement device | |
JP2004532079A (en) | Portable interstitial fluid monitoring system | |
US20160029935A1 (en) | Analyte sensors, systems, testing apparatus and manufacturing methods | |
JP4576626B2 (en) | Manufacturing method of puncture device integrated biosensor | |
JP5126756B2 (en) | Puncture device integrated biosensor and its manufacturing method | |
JP2004033374A (en) | In vivo information detection unit | |
AU2006202678A1 (en) | Percutaneous biological fluid sampling and analyte measurement devices and methods |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG UZ VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG UZ VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2002725341 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 2002725341 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
NENP | Non-entry into the national phase |
Ref country code: JP |
|
WWW | Wipo information: withdrawn in national office |
Country of ref document: JP |